MORGAN PLAISANCE: Open Payments
NPI 1528579836 · CARENCRO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 33 payments from 8 companies in 2025. Trend: 2023 $1,090 · 2024 $390 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $197 |
| Alkermes, Inc. | 13 | $193 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: VRAYLAR, ARISTADA, FANAPT, CAPLYTA, COBENFY, INGREZZA, TRINTELLIX, ABILIFY ASIMTUFII.
Industry payments across LA — which companies pay providers there.
